Ok. Suckii is correct.
Enough of me.
You know my opinions on corporate govenence, the importance of direct director shareholdings ie "skin in the game" and that the ASX framework in which companies raise capital needs government reform.
You know my biases - I have once been a holder therefore I have negative confirmation bias.
And you know my opinions on HC as a forum to discuss the prospects of a company.
Cherrio. Go Admedus. All IMHO and Good luck to all holders.
This time I mean it.
Good bye. JG.
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-251
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.19 |
Change
-0.010(0.08%) |
Mkt cap ! $257.6M | |||
| Open | High | Low | Value | Volume |
| $12.19 | $12.20 | $11.60 | $173.1K | 14.51K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9 | $11.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.19 | 28 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |